A sugar‐coated strategy to treat a rare neurologic disease provides a blueprint for a decoy glycan therapeutic and a potential vaccine for CoViD‐19
An Editorial Highlight for “Selective inhibition of anti‐MAG IgM autoantibody binding to myelin by an antigen specific glycopolymer”on https://doi.org/10.1111/jnc.15021
STEINMAN

Abstract
Abstract

In a rare neurologic disease known as IgM monoclonal gammopathy the immune system targets a sulfated tris